196 results
10-K
2022 FY
EX-10.7
ALT
Altimmune Inc
Annual report
28 Feb 23
12:00am
10-K
2022 FY
EX-10.30
ALT
Altimmune Inc
Annual report
28 Feb 23
12:00am
8-K
EX-10.1
ALT
Altimmune Inc
13 Dec 21
Altimmune Appoints Richard Eisenstadt as Chief Financial Officer
6:30am
10-Q
2021 Q3
EX-10.1
ALT
Altimmune Inc
Quarterly report
9 Nov 21
12:00am
10-Q
2021 Q2
EX-10.1
ALT
Altimmune Inc
Quarterly report
10 Aug 21
4:10pm
8-K
EX-10.1
d3rq9tso6x37639f5t96
25 Feb 21
Enrollment in the Phase 1 AdCOVID™ Clinical Trial has Commenced
7:06am
8-K
EX-10.1
1d42q6vhbz2jq8 4v
9 Jul 19
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
7:58am